EUVIMEDOtkrijte EUVIMED
BeobachtungsstudieOpen access

Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion

Wangwei Yang, Xingqiang He iD, Jianzheng Liu, Fangjun Mou, Yi Liu, Zhiyong Yin, Fei Li, Jingyu Zhou, Haokao Gao, Tao Hu, Robert-Jan van Geuns iD, Yoshinobu Onuma and 3 more

Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 376-387

DOI: 10.1002/ccd.70653 ↗

At a glance

Beobachtungsstudie in Catheterization and Cardiovascular Interventions, published online on 2026-05-17. Written by Wangwei Yang and 14 co-authors. Institution: Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. Major MEDLINE topics: Paclitaxel, Angioplasty, Balloon, Coronary, Coronary Restenosis, Fractional Flow Reserve, Myocardial. 39 references. The full text is freely available in PubMed Central. Funded by: The Innovation Support Program of Shaanxi Province of China.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Background

The clinical impact of angiography‐based, computational pressure‐flow dynamics derived FFR (caFFR) after paclitaxel‑coated balloon (DCB) angioplasty remains unclear.

Aims

To investigate the prognostic value of post‐procedural caFFR in the treatment of in‐stent restenosis (ISR) with DCB.

Methods

Consecutive patients undergoing DCB angioplasty for ISR at Xijing Hospital, China, between December 2015 and December 2019 were prospectively enrolled. The primary endpoint was vessel‐oriented composite endpoint (VoCE), defined as a composite of vessel‐related cardiovascular death, target‐vessel myocardial infarction (TV‐MI), and ischemia‐driven target vessel revascularization (ID‐TVR) at 3‐year, assessed at the vessel level.

Results

A total of 1055 vessels treated with DCB were screened, and the post‐procedural caFFR was analyzable in 999 (94.7%). At 3‐year, 149 VoCE (14.9%) and 98 ID‐TVR (9.8%) events occurred. Maximally‐selected log‐rank statistics respectively identified post‐procedural caFFR value of 0.87 and post‐procedural %DS of 28 as the optimal cutoff points to predict VoCE. Post‐procedural caFFR demonstrates the superior predictive ability for VoCE compared to post‐procedural %DS (NRI: 7.4%, p < 0.001). A negative correlation was discerned between post‐procedural caFFR value and VoCE (HR per 0.1 increase : 0.72, 95% CI: 0.53–0.98, p = 0.039). Post‐procedural caFFR ≤ 0.87 group was associated with a 1.5‐fold increase in the risk of VoCE (HR IPTW : 1.53, 95% CI: 1.02–2.29) and a 1.8‐fold increase in ID‐TVR (HR IPTW : 1.82, 95% CI: 1.15–2.89).

Conclusions

A higher post‐procedural caFFR value is associated with improved vessel‐related clinical outcomes in patients of ISR treated by DCB. Achieving a post‐procedural caFFR value of 0.87 in the treated vessels may represent a reasonable procedural goal. Trial Registration Clinicaltrial.gov identifier: NCT05133921

Subjects

MeSH terms (MEDLINE)

PaclitaxelAngioplasty, Balloon, CoronaryCoronary RestenosisFractional Flow Reserve, MyocardialCardiovascular AgentsCoated Materials, BiocompatibleCardiac CathetersCoronary Artery DiseaseStentsPercutaneous Coronary InterventionDrug-Eluting StentsHumansPredictive Value of TestsTime FactorsTreatment OutcomeProspective StudiesFemaleMaleAgedMiddle AgedRisk FactorsCoronary AngiographyChina

Author keywords

computational pressure‐flow dynamics derived FFRdrug‐coated balloonin‐stent restenosis

Substances

PaclitaxelCardiovascular AgentsCoated Materials, Biocompatible

Authors and institutions

  • Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
  • Department of Cardiology, University of Galway, Galway, Ireland.
  • Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Cardiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.

ORCID profiles: Xingqiang He, Robert-Jan van Geuns, Patrick W Serruys, Chao Gao

Funding

  • The Innovation Support Program of Shaanxi Province of China

Cite

APA

Yang, W., He, X., Liu, J., Mou, F., Liu, Y., Yin, Z., Li, F., Zhou, J., Gao, H., Hu, T., van Geuns, R. J., Onuma, Y., Serruys, P. W., Gao, C., & Tao, L. (2026). Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion. Catheterization and Cardiovascular Interventions, 108(2), 376-387. https://doi.org/10.1002/ccd.70653

Vancouver

Yang W, He X, Liu J, Mou F, Liu Y, Yin Z, et al. Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion. Catheterization and Cardiovascular Interventions. 2026;108(2):376-387. doi:10.1002/ccd.70653

BibTeX
@article{Yang2026,
  author = {Yang, Wangwei and He, Xingqiang and Liu, Jianzheng and Mou, Fangjun and Liu, Yi and Yin, Zhiyong and Li, Fei and Zhou, Jingyu and Gao, Haokao and Hu, Tao and van Geuns, Robert-Jan and Onuma, Yoshinobu and Serruys, Patrick W and Gao, Chao and Tao, Ling},
  title = {Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {108},
  number = {2},
  pages = {376--387},
  doi = {10.1002/ccd.70653}
}
Start for free →